1-3 of 3
Amber Donahue
Close
Sort by
Journal Articles

Plasma Circulating Ki-67 Index as a Biomarker and Prognostic Indicator in Patients with Chronic Lymphocytic Leukemia.

Jean-Marie Bruey, Zeev Estrov, Hagop M. Kantarjian, MD, Wanlong Ma, Chen-Hsiung Yeh, William Weirda, Amber Donahue, Susan O'Brien, Michael Keating, MD, Maher Albitar, MD
Journal: Blood
Blood (2009) 114 (22): 1261.
https://doi.org/10.1182/blood.V114.22.1261.1261
Published: 2009
Journal Articles

Proteasome Chymotrypsin-Like Activity in Plasma Is a Major Predictor of Outcome in Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Normal Karyotype.

Wanlong Ma, Iman Jilani, Ph.D., Benjamin Bekele, Hagop Kantarjian, M.D., Amber Donahue, Ph.D., Xi Zhang, Zhong Zhang, M.D., Susan O’Brien, M.D., Elihu Estey, M.D., Zeev Estrov, M.D., Jorge Cortes, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2007) 110 (11): 2837.
https://doi.org/10.1182/blood.V110.11.2837.2837
Published: 2007
Journal Articles

Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Myeloid Leukemia.

Wanlong Ma, Hagop Kantarjian, M.D., Amber Donahue, Ph.D., Xi Zhang, Susan O’Brien, M.D., Iman Jilani, Ph.D., Elihu Estey, M.D., Zeev Estrov, M.D., Jorge Cortes, M.D., Michael Keating, M.D., Francis Giles, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2007) 110 (11): 4546.
https://doi.org/10.1182/blood.V110.11.4546.4546
Published: 2007